Funded Tech Companies

Arisaph Pharmaceuticals

Arisaph Pharmaceuticals is a biopharmaceutical company, based in Boston. Financial backing came from private investors.

Company Overview

Company Name
Arisaph Pharmaceuticals
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
100 High St. 1202
Boston, MA 02110
USA
Email Address

Company Background Information

Overview
Arisaph is an emerging biopharmaceutical company focused on developing novel therapies for cancer, cardiovascular disease and diabetes. The company utilizes proprietary drug discovery platforms to develop differentiated medicines that are highly potent and act selectively on validated targets.
Profile
Arisaph Pharmaceuticals LinkedIn Company Profile
Social Media
Arisaph Pharmaceuticals Company Twitter Account
Company News
Arisaph Pharmaceuticals News
Facebook
Arisaph Pharmaceuticals on Facebook
YouTube
Arisaph Pharmaceuticals on YouTube
Last Transaction
11/1/2013

Financing History

Date
Type
Amount
Venture Equity
$10,000,000
Venture Equity
$8,000,100


Management Team

Title
Name
Email & Social
Chief Executive Officer
Christopher Kiritsy
  Christopher Kiritsy LinkedIn Profile  Christopher Kiritsy Twitter Account  Christopher Kiritsy News  Christopher Kiritsy on Facebook
Chief Scientific Officer
William Bachovchin
  William Bachovchin LinkedIn Profile  William Bachovchin Twitter Account  William Bachovchin News  William Bachovchin on Facebook
VP - Finance
Joseph Suarez
  Joseph Suarez LinkedIn Profile  Joseph Suarez Twitter Account  Joseph Suarez News  Joseph Suarez on Facebook


Company Investors

     

     

     

    Browse more funded tech companies:

    Aris Radiology | Arisdyne Systems

     

    Share this article

     


    About Our Venture Capital Database

    This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

     


    Additional Resources for Entrepreneurs

    Lists of Venture Capital and Private Equity Firms

    Franchise Opportunities

    Contributors

    Business Glossary